This press release gets the ball rolling, as I’ve been following these guys for some time now.
The appointment of Brendan Purdy just icing on the cake as……this guy has raised “serious capital” in the space.
Evitrade trades as EVA and is significantly undervalued in my view…..blockchain for medical services?? Hello!?
I’m watching for more news and much higher stock prices as early as Wednesday.
EVITRADE HEALTH SYSTEMS to Develop Medical Blockchain Technologies, appoints Mr. Brendan Purdy as COO to Division, and to Seek Opportunity to Up-List on Senior Exchange
VANCOUVER, BC, Monday November 20th, 2017 – EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: AXHLF) (the “Company” or “EVITRADE”) is pleased to announce that it intends to focus its efforts on developing the medical blockchain services and applications aspects of its healthcare software system. The company is also pleased to announce that Mr. Brendan Purdy, JD has been appointed as Interim COO of the medical blockchain & data security division, and to be a member of the business advisory committee The company expects to also seek an opportunity to list on a senior exchange subject to meeting any and all financing, regulatory, and listing requirements.
Mr. Purdy currently serves on the board of Global Blockchain Technologies Inc, Enforcer Gold Corp, and is also CEO and Director of High Hampton Holdings Corp. Additionally, Mr. Purdy has previously acted as CEO of Enforcer Gold Corp. (formerly Natan Resources Ltd.) and Seaway Energy Services Inc., both TSX-V listed mining issuers.
In addition, Mr. Purdy is an active practicing securities lawyer focused on technology, medical, and resource issuers. In his private practice, he has developed domestic and international experience with respect to public companies, reverse takeovers, mergers and acquisitions (M&A) and many facets fundamental to successful transactions at all levels of capital market transactions. Prior to receiving his J.D. from the common-law section at the University of Ottawa, Mr. Purdy completed a bachelor of management and organizational studies degree from the University of Western Ontario, majoring in finance and administration.
“I am glad to finally be able to bring Brendan on board in a more formal capacity; his breath of experience in the blockchain technology, medical cannabis, and capital markets sector will be instrumental to both business and corporate development” said Syd Au, Chairman and CEO.
Management believes that there is significant value to be realized from developing the medical blockchain aspects from its digital healthcare software application as well as from seeking and potentially up-listing on a senior non-Canadian exchange. Both these events may provide better opportunities for financing, visibility and increasing shareholder value and management looks forward to providing updates as soon as possible.
On behalf of the Company:
About EVITRADE Health Systems Corporation
EVITRADE Health Systems Corporation (formerly Auxellence Health Corp.), (CSE: EVA, OTCQB: AXHLF), was founded in 2013 to provide online “digital healthcare” services for resolving common health problems.
Disclaimers – Forward Looking Statements
This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, http://thecse.com/en/listings/technology/evitrade-health-systems-corp, and http://www.otcmarkets.com/stock/AXHLF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.